Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-02-20 @ 1:24 AM
Study NCT ID:
NCT03742258
Status:
COMPLETED
Last Update Posted:
2025-06-18
First Post:
2018-11-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma
Sponsor:
Northwestern University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-08
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-12
First Submit QC Date:
None
Study First Post Date:
2018-11-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-02
Results First Submit QC Date:
None
Results First Post Date:
2025-01-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-03
Last Update Post Date:
2025-06-18
Last Update Post Date Type:
ACTUAL